Complix is a biopharmaceutical company developing Alphabodies, a novel class of biopharmaceuticals. Complix is a biopharmaceutical company developing a pipeline of transformative Cell Penetrating Alphabody (CPAB) based biotherapeutics active against cutting-edge and challenging intracellular targets that play a key role in life threatening diseases, including cancer.
Complix’s goal is to use its unique Alphabody technology ...
Complix is a biopharmaceutical company developing Alphabodies, a novel class of biopharmaceuticals. Complix is a biopharmaceutical company developing a pipeline of transformative Cell Penetrating Alphabody (CPAB) based biotherapeutics active against cutting-edge and challenging intracellular targets that play a key role in life threatening diseases, including cancer.
Complix’s goal is to use its unique Alphabody technology to develop transformative biotherapeutics for applications in viral diseases, oncology, immuno-oncology and autoimmunity and deliver value for its stakeholders in a large therapeutic area with high unmet medical need.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.